On 11 February, Immune Design (NASDAQ:IMDZ), announced the start of a Phase 1 clinical trial of G100 in combination with radiation therapy in patients with metastatic sarcoma. On Wednesday shares of Immune Design Corp. (NASDAQ:IMDZ) closed at $24.21. Company’s EPS growth for next 5 years is recorded as 5.00%.

WaferGen Bio-systems, Inc. (NASDAQ:WGBS) in last trading activity advanced 8.70% to close at $5.00. Company weekly performance is 53.85% while its quarterly performance stands at 23.15%. WaferGen Bio-systems, Inc. (NASDAQ:WGBS) is -83.33% away from its 52 week high.

Mead Johnson Nutrition Company (NYSE: MJN) announced that it presented at the 2015 Consumer Analyst Group of New York (CAGNY) Conference in Boca Raton, Florida on Tuesday, February 17, 2015. On last trading day Mead Johnson Nutrition Company (NYSE:MJN) advanced 0.51% to close at $104.02. Its volatility for the week is 1.98% while volatility for the month is 2.02%. MJN’s sales growth for past 5 years was 9.30% and its EPS growth for past 5 years was 12.30%. Mead Johnson Nutrition Company (NYSE:MJN) monthly performance is 3.66%.

Nordstrom Inc. (NYSE: JWN) declared a quarterly dividend of $0.37 per share, or $1.48 annualized. This is a 12.1% increase from the prior dividend of $0.33. The dividend will be payable on March 13, 2015, to stockholders of record on February 27, 2015, with an ex-dividend date of February 25, 2015. Nordstrom Inc. (NYSE:JWN) has 8.10% insider ownership while its institutional ownership stands at 56.50%. In last trading activity company’s stock closed at $78.05.

OvaScience Inc. (NASDAQ:OVAS) announced that Company management presented at the Leerink Global Healthcare Conference on Wednesday, February 11, 2015. On last trading day OvaScience, Inc. (NASDAQ:OVAS) advanced 2.34% to close at $45.45. Its volatility for the week is 4.65% while volatility for the month is 6.44%. OvaScience, Inc. (NASDAQ:OVAS) monthly performance is -9.43%.